An Open-Label Trial Measuring Satisfaction and Convenience of Two Formulations of Lamotrigine in Subjects With a Mood Disorder.
Phase of Trial: Phase III
Latest Information Update: 04 Jun 2015
At a glance
- Drugs Lamotrigine (Primary)
- Indications Affective disorders
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 01 May 2009 Actual end date (Feb 2008) added as reported by ClinicalTrials.gov.
- 01 May 2009 Actual number of patients (97) added as reported by ClinicalTrials.gov.
- 01 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.